ASCO 2022: ICR researchers hit the headlines with innovative approaches to cancer treatment and care 08 Jun 2022 The first in-person ASCO conference since the start of the Covid-19 pandemic took place in Chicago over the weekend. Many researchers from the ICR and The Royal Marsden presented their work in the form of talks or posters. Here we look back over some of our highlights of this year’s meeting. Find out more Show/Hide
“I think the cancer is done now” – Gerry’s story 29 Mar 2022 Gerry was diagnosed with prostate cancer in 2000. During Prostate Cancer Awareness Month, he tells us what research has brought him. Find out more Show/Hide
How reliable are direct-to-consumer genetic tests when interpreting cancer risk? 22 Feb 2022 At-home genetic testing has gained a lot of traction in recent years, raising many ethical issues. Diana Cano talked to world-leading cancer genetics expert Professor Ros Eeles to find out more about the promises and dangers of direct-to-consumer tests in helping to manage cancer risk. Find out more Show/Hide
A targeted prostate cancer screening programme could be possible in five years - what will it look like? 28 Jan 2022